Skip to content
Medical Health Aged Care

Monash Professor joins PM in being named in TIME Magazine’s 100HEALTH list

Monash University 2 mins read

Monash University’s Professor Catriona Bradshaw, from the Sub Faculty of Translational Medicine and Public Health, in Medicine, Nursing and Health Sciences, and The Alfred’s Melbourne Sexual Health Centre, has been named as a member of the 2025 TIME100 Health, the annual list – by TIME Magazine – of the world leaders shaping the future of health.

Professor Bradshaw has achieved this honour in recognition of her more than 20 years researching the condition, bacterial vaginosis (BV), a condition affecting one in four women of reproductive age worldwide and causing miscarriage, premature births and increased risk of HIV.

Professor Bradshaw believed that the traditional understanding and treatment of BV as an imbalance (disruption) of the vaginal microbiome, led to the condition being wrongly managed, and treated exclusively as a female condition only, resulting in more than 50 per cent of women experiencing rapid recurrence.

As the principal investigator on a landmark study published in March in the New England Journal of Medicine (NEJM), her work revealed that BV is in fact a sexually transmitted infection (STI), paving the way for a revolution in how it is treated. 

An accompanying editorial in the NEJM, said the study would lead to a “major paradigm shift” in the way the condition will be treated, essentially with a simple, short and cheap course of topical and oral antibiotics given to male partners of women at the time they are treated for BV.

TIME Magazine said that Professor Bradshaw’s inclusion in the TIME100Health list was due to her contribution in “leading change in health and driving meaningful change toward a healthier world for all.”

Professor Bradshaw said it was an enormous honour to be recognised in the List, “which belongs to my colleagues in this study as well,” she said.

“At a time when sexual health and women’s health research is under-valued and threatened, this award has even greater significance and meaning,” she added.

ENDS

For more Monash media stories, visit our news and events site  


Contact details:

Monash University

Tania Ewing Media and Communications Contractor
E: [email protected] 

T: +61 (0) 408 378 422


For general media enquiries please contact:
Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

Media

More from this category

  • Medical Health Aged Care
  • 24/05/2025
  • 05:30
Dementia Australia

Join us today for the Redcliffe Memory Walk & Jog

What: Dementia Australia’s Redcliffe Memory Walk & Jog    When: Saturday 24 May from 7:30am   Who: More than 600 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guests Pat Welsh and Wally Lewis.   Where: Scarborough Beach Park, Redcliffe    Dementia Australia spokespeople are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: https://www.memorywalk.com.au/event/redcliffe/home Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with dementia, and…

  • Contains:
  • Medical Health Aged Care
  • 23/05/2025
  • 11:01
Dementia Australia

Memory Walk & Jog Brisbane just weeks away!

The 2025 Brisbane Memory Walk & Jog is just a few short weeks away, with the event taking place on Sunday, 8 June at Rocks Riverside Park, Seventeen Mile Rocks. Following overwhelming support for last year's Brisbane Memory Walk & Jog, we are returning bigger and better for another year. Memory Walk & Jog Brisbane will help advance the work of Dementia Australia, which delivers invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported. We are in this together, which is…

  • Contains:
  • Medical Health Aged Care
  • 23/05/2025
  • 07:56
Merck

Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025

Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated with…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.